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Abstract
Background: Pleckstrin homology (PH) domains are common membrane-targeting modules and their best characterized
ligands are a set of important signaling lipids that include phosphatidylinositol phosphates (PtdInsPs). PH domains
recognize PtdInsPs through two distinct mechanisms that use different binding pockets on opposite sides of the b-
strands 1 and 2: i) a canonical binding site delimited by the b1-b2 and b3-b4loops and ii) a non-canonical binding site
bordered by the b1-b2 and b5-b6loops. The PH domain-containing protein Slm1 from budding yeast Saccharomyces
cerevisiae is required for actin cytoskeleton polarization and cell growth. We recently reported that this PH domain binds
PtdInsPs and phosphorylated sphingolipids in a cooperative manner.
Principal Findings: To study the structural basis for the Slm1-PH domain (Slm1-PH) specificity, we co-crystallized this
domain with different soluble compounds that have structures analogous to anionic lipid head groups of reported Slm1
ligands: inositol 4-phosphate, which mimics phosphatidylinositol-4-phosphate (PtdIns(4)P), and phosphoserine as
a surrogate for dihydrosphingosine 1-phosphate (DHS1-P). We found electron densities for the ligands within the so-
called non-canonical binding site. An additional positively charged surface that contacts a phosphate group was identified
next to the canonical binding site.
Conclusions: Our results suggest that Slm1-PH utilizes a non-canonical binding site to bind PtdInsPs, similar to that
described for the PH domains of b-spectrin, Tiam1 and ArhGAP9. Additionally, Slm1-PH may have retained an active
canonical site. We propose that the presence of both a canonical and a non-canonical binding pocket in Slm1-PH may
account for the cooperative binding to PtdInsPs and DHS-1P.
Citation: Anand K, Maeda K, Gavin A-C (2012) Structural Analyses of the Slm1-PH Domain Demonstrate Ligand Binding in the Non-Canonical Site. PLoS ONE 7(5):
e36526. doi:10.1371/journal.pone.0036526
Editor: Beata G. Vertessy, Institute of Enzymology of the Hungarian Academy of Science, Hungary
Received October 29, 2011; Accepted April 2, 2012; Published May 4, 2012
Copyright:  2012 Anand et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was partially funded by the Federal Ministry of Education and Research (BMBF; FKZ0315162) in the framework of the BioChancePLUS-4 to
ACG. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or
preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: gavin@embl.de (ACG); anand@embl.de (KA)
Introduction
Pleckstrin homology (PH) domains are short segments of
approximately 120 amino acids and are present in a wide range
of proteins. Despite their poor conservation at the sequence level,
PH domains share a common fold that consists of a seven-stranded
antiparallel b-sheet and a C-terminal amphipathic a-helix
(Figure 1A). The human genome and that of the yeast Saccharomyces
cerevisiae encode at least 252 and 27 proteins, respectively, that
contain one or several PH domains and these are involved in
a wide range of biological processes, including cellular signaling,
cytoskeleton organization, membrane trafficking and lipid metab-
olism [1,2].
The best-characterized ligands for PH domains are phospha-
tidylinositol phosphates (PtdInsPs) [1,3,4,5,6,7,8,9,10,11] and
binding to this important class of signaling lipid contributes to
protein recruitment to cellular membranes. The ligand specificity
of each PH domain is variable. For example, the PH domain of
phospholipase Cd (PLCd) binds phosphatidylinositol-4,5-bispho-
sphates (PtdIns(4,5)P2) with high affinity (KD=2mM [1]), whereas
the affinity of the dynamin 1 PH domain for the same
phospholipid is in the millimolar range. The protein kinase B
(b/akt) PH domain, on the other hand, binds PtdIns(3,4,5)P3 and
PtdIns(3,4)P2 with similar affinities, but does not bind to PtdIns(3)P
or PtdIns(3,5)P2. However, only a minority of PH domains
actually target PtdInsPs with high specificities and affinities and in
fact, the vast majority of PH domains either poorly discriminate
between different PtdInsPs or do not bind lipids at all
[12,13,14,15]. Accordingly, some PH domains have been pro-
posed to mediate protein-protein interactions or to bind proteins
and lipids through cooperative mechanisms [16].
Both X-ray crystallography and nuclear magnetic resonance
spectroscopy (NMR) have been used to understand the structural
determinants of lipid recognition by PH domains. In general, head
groups of PtdInsPs are accommodated on a positively charged
surface of PH domains and two main binding modes have been
described to date (Figure 1A). First, a so-called canonical binding
site has been characterized that uses positively charged residues
located between the b1-b2, b3-b4 and b6-b7 loops. Canonical
binding sites have been reported for a variety of PH domains, such
PLoS ONE | www.plosone.org 1 May 2012 | Volume 7 | Issue 5 | e36526as those of PLCd and b/akt [6,8]. Second, a non-canonical
binding site has been observed for the PH domain of b-spectrin,
Tiam1 and ArhGAP9 that is formed between the b1-b2 and b5-b6
loops, adjacent to the canonical site but on the other side of the b1-
b2 loop [17,18,19].
The PH domain-containing protein Slm1 from S. cerevisiae is
a component of the target of rapamycin complex 2 (TORC2)
signaling pathway. Slm1 plays a role in the regulation of actin
organization [20] and is also a target of sphingolipid signaling
during the heat shock response [10]. The PH domain of Slm1 is
known to bind to PtdIns(4,5)P2 [20], and also PtdIns(4)P and
a phosphorylated sphingolipid species, dihydrosphingosine 1-
phosphate (DHS-1P) [12] (Figure S1). We have previously
reported that in vitro, the Slm1-PH domain (Slm1-PH) interacts
with liposomes containing PtdIns(4,5)P2 and DHS-1P coopera-
tively. Similarly, in vivo Slm1 association with specialized mem-
brane microdomains, the eisosomes, requires the metabolism of
both PtdIns(4,5)P2 and sphingolipids [12]. This led to the view that
the recruitment of Slm1-PH to cellular membranes might involve
a novel mechanism, in which not only PtdInsPs but also
phosphorylated sphingolipids could act as anchoring ligands. We
previously reported a structure for the apo Slm1-PH (at 2.0 A ˚) that
depicted only part of the non-canonical binding site. This revealed
that Slm1-PH might possess two binding sites for anionic lipids
[12]. However, in the absence of a ligand-bound holo structure,
the detailed modalities of ligand recognition remained largely
elusive.
Here we report the crystal structure of the apo form of Slm1-PH
domain at 1.76 A ˚ resolution together with the holo Slm1-PH
bound to different mimics of lipid head groups: i) a 1.68 A ˚
resolution structure of Slm1-PH in complex with phosphoserine
(surrogate of DHS-1P head group) and ii) 1.4 A ˚ and 1.8 A ˚
resolution structures of Slm1-PH in complex with inositol 4-
phosphate (Ins(4)P; surrogate of the PtdIns(4)P head group). The
results show that the non-canonical binding site of Slm1-PH is
used for ligand binding, similar to the site described previously for
b-spectrin, Tiam1 and ArhGAP9 [17,18,21] and which therefore
suggests that this interaction mode has been conserved in yeast.
Furthermore, our data also support the existence of an active
canonical binding site in Slm1-PH, thus providing a structural
model for the previously reported cooperativity between PtdInsPs
and DHS-1P binding [12].
Figure 1. Overall structure of the Slm1-PH domain. (A) Ribbon representation of the 1.76 A ˚ structure (green) showing that Slm1-PH folds into
a seven-stranded b-sheet terminated with an a-helix. All secondary structure elements are labeled in yellow and black. Both canonical and non-
canonical binding sites are also marked. (B) In the X-ray crystal structure the canonical binding site is partially occluded by the b5-b6 loop (in red) of
the neighboring molecules (in yellow and violet) on both sides. The b1-b2 loops of all the molecules are shown in blue. All the loops in Figure 1B have
been smoothened using PyMOL for clarity. (C) Detailed view of the interactions between the b1-b2 loop and the b5-b6 loop of neighboring
molecules. Primarily, the side-chain residues of the b5-b6 loop are making contact with the main-chain atoms of the b1-b2 loop region.
doi:10.1371/journal.pone.0036526.g001
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Ligand screening for the Slm1-PH domain
Previous experiments, based on isothermal titration calorimetry
(ITC), have shown that Slm1-PH binds weakly to PtdIns(4,5)P2 or
DHS-1P alone. Both lipids need to be present for the interaction to
reach affinities of 1.8 mM [12], which is similar to those observed
for other PH domain-ligand pairs such as PLCd-PH and
PtdIns(4,5)P2 (1.7 mM; [6]) or b-spectrin and PtdIns(4,5)P2
(40 mM; [18]). To understand the interactions and specificities of
Slm1-PH in complex with surrogate lipid head groups, more than
50 crystallization experiments were screened that included both
co-crystallization and soaking techniques. Seven different soluble
compounds that mimic PtdInsPs and DHS-1P head groups
(Figure S1) were used either alone or in combination. These
included various inositol phosphates (InsPs), phosphoserine, the
sphingosine analog FTY720 and its phosphorylated derivative,
FTY720(P) [22,23,24] (Table 1). Only co-crystallization experi-
ments with bound ligands produced acceptable diffraction data.
The results presented here include: (i) the apo structure of Slm1-
PH that we resolved at 1.76 A ˚ resolution; (ii) one structure with
phosphoserine at 1.68 A ˚ resolution; and (iii) two structures of
Slm1-PH in complex with Ins(4)P at 1.4 and 1.8 A ˚ resolution
(Tables 1 and 2).
Overall structure of the Slm1-PH domain
Although the sequence identity with other PH domains is rather
low (,18%), the overall fold of Slm1-PH is similar to previously
determined structures of PH domains [6,16,17,18,25] (Figure 1A).
The core of each monomer consists of seven antiparallel b-strands
with a C-terminal amphipathic a-helix connected via a long and
flexible loop. The loops connecting the b-sheets, especially b3-b4
and b5-b6 (residues 501-512 and residues 526-542, respectively),
are long and constitute putative ligand-binding sites. The interior
of the core consists of hydrophobic residues. Electron densities
corresponding to the Ins(4)P molecules were visible between the
b1-b2 and b5-b6 loop regions (difference density maps; Fig-
ure S2). In addition, all structures in complex with ligands show
regions of additional density between the bottom of the b1-b2 loop
and the N-terminus of Slm1-PH. Intriguingly, we could not assign
any ligand to these extra densities. Interestingly for all four
structures, much of the binding space in the canonical binding site
is occupied by the b5-b6 loop of the neighboring molecule
(Figure 1B and C). As the interactions between the two molecules
involve the backbone of b1-b2 and no specific side-chain residue,
this probably represents a crystallographic packing artifact.
Compared with our previously published structure at 2 A ˚ [12],
our new apo structure clearly visualizes the full b5-b6 loop, which
plays a key role in accommodating ligand molecules in the non-
canonical binding site (see below).
The Slm1-PH domain binds lipid via a non-canonical
binding site
In our complex crystal structures, all negatively charged ligands
localize to the non-canonical binding site defined by the flexible
loops b1-b2 and b5-b6, which form a wide and shallow pocket
(Figure 1A). As described for other PH domains, the b1-b2 sheets
and their connecting loop play a central role in ligand binding
(Figure 2) [2,5,8,11,16,17,18,26,27]. For the two structures
determined in complex with Ins(4)P, the positions of the inositol
ring overlap. In both cases, the oxygen atoms of the inositol ring
contact the b1-b2 region through the hydroxyl group of Tyr485
(hydrogen bond length =2.8 A ˚) and the NH2 group of Arg478
(hydrogen bond length =2.5 A ˚), and the b5-b6 loop through the
Table 1. Crystallographic screening for Slm1-PH domain ligands.
Surrogate ligands Result Lipid
Apo Slm1-PH 1.76 A ˚ resolution Holo form
Ins(4)P 1.4 A ˚ resolution; Ins(4)P bound PtdIns(4)P
Ins(4)P 1.8 A ˚ resolution; Ins(4)P bound PtdIns(4)P
PS+Ins(1,4,5)P3 1.68 A ˚ resolution; Phosphoserine bound DHS-P + PtdIns(4,5)P2
PS+Ins(4)P 2.7 A ˚ resolution; Phosphoserine bound DHS-1P + PtdIns(4)P
FTY720(P)+Ins(4,5)P2 1.6 A ˚ resolution; No bound ligand DHS-1P + PtdIns(4,5)P2
Ins(3)P 1.7 A ˚ resolution; No bound ligand PtdIns(3)P
PS+Ins (3)P 1.6–1.8 A ˚ resolution; No bound ligand DHS-1P + PtdIns(3)P
PS+Ins(4,5)P2 2.0 A ˚ resolution; No bound ligand DHS-1P + PtdIns(4,5)P2
PS+Ins(1,4,5)P3 2.5 A ˚ resolution; No bound ligand DHS-1P + PtdIns(4,5)P2
Ins(1,4,5)P3 2.5 A ˚ resolution; but only in one direction PtdIns(4,5)P2
Ins(1,4,5)P3 2.6 A ˚ resolution; No bound ligand PtdIns(4,5)P2
PS+Ins(1,4,5)P3 3.1 A ˚ resolution; No bound ligand DHS-1P + PtdIns(4,5)P2
Ins(4,5)P2 3.4 A ˚ resolution; No bound ligand PtdIns(4,5)P2
PS+Ins(1,4,5)P3 4.5 A ˚ resolution; No bound ligand DHS-1P + PtdIns(4,5)P2
FTY720 Too mosaic diffraction to process so far DHS
Ins(4)P+Ins(1,4,5)P3 No diffraction PtdIns(4)P+ PtdIns(4,5)P2
FTY720(P)+Ins(4)P No crystals DHS-1P + PtdIns(4)P
*PS = phosphoserine.
*Crystals of the same protein-ligand complex were obtained in different crystallization conditions.
*FTY720 = synthetic analog of sphingosine, currently studied as a potent immunosuppressive and immunomodulatory agent [22,23,24]; FTY720(P) = phophorylated
FTY720.
doi:10.1371/journal.pone.0036526.t001
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addition, we observed a contact with the e-amino group of Lys562
(hydrogen bond length =3.2 A ˚) from the b6-b7 strand. In-
terestingly, the two structures differ with respect to the orientation
of the phosphate at position 4 (P4), which contacts either the b1-b2
loop or turns 180
u and contacts the b5-b6 loop (Figure 2A, C). In
the first case, the main-chain nitrogen of Tyr485 and the carbonyl
oxygen of Ser484 (hydrogen bond lengths =3.0 and 3.1 A ˚,
respectively) of the b1-b2 loop region interact with P4 (Figure 2A),
whereas in the other structure the main-chain nitrogen atom of
Ser539 of the b5-b6 loop forms hydrogen bonds of 2.6 A ˚ with the
oxygen atom of P4 (Figure 2C).
The phosphoserine contacts the b1-b2 region and the b5-b6
loop through the same key residues as Ins(4)P (Figure 2D).
Specifically, the hydroxyl group of Tyr485 hydrogen bonds with
the nitrogen atom of phosphoserine (hydrogen bond length
=2.9 A ˚) and the NH2 group of Arg478 interacts with the oxygen
atom of phosphoserine (hydrogen bond length =2.8 A ˚). In
addition, the e-amino group of Lys542 from the b5-b6 loop and
the e-amino group of Lys562 from the b7-strand also interact with
the phosphate group of the phosphoserine molecule (hydrogen
bond lengths =2.4 A ˚ and 2.7 A ˚, respectively).
Overall, the ligands show very similar binding modalities and
when superposed on each other, they all share common positions
in the non-canonical binding site that overlap with previously
observed positions of sulfate ions in the holo form of Slm1-PH
(Figure 3A). In the non-canonical binding site there are four
residues that are consistently involved in ligand binding: Arg478,
Tyr485, Lys542 and Lys562. Of these, Arg478 is conserved
among PH domains that contain non-canonical binding sites.
Interestingly, Arg478 has been shown to be important for ligand
binding in vivo by mutation analysis [12]. We subsequently docked
Table 2. Data collection and refinement statistics.
Apo
Phosphoserine and
malonate Ins(4)P
Ins(4)P (inverted phosphate
group)
X-ray source Synchrotron
a Synchrotron
b Synchrotron
a Synchrotron
a
Detector ADSC Q105 CCD @ ESRF MAR225 @ SLS ADSC Q105 CCD @ ESRF ADSC Q105 CCD @ ESRF
Wavelength (A ˚) 0.97242 1.0000 1.06650 1.06650
Temperature (K) 100 100 100 100
Resolution (A ˚) at which data
were collected
1.60 1.60 1.40 1.75
Data Statistics for refined atoms
Space group P21 P22121 P21 P21
No. of molecules in a.u. 4 2 4 4
Unit cell dimensions 37.3,82.3,76.4, b=90.1 37.5,73.6.82.5, b=90.01 37.0,71.6.82.7, b=90.02 37.0,71.6.82.6, b=90.1
Rmeas
c (%) 4.4 (30.0) 9.7 (53.5) 4.5 (53.2) 5.0 (35.0)
I/s 26.02 (5.0) 10.6 (3.3) 16.6 (2.5) 18.7 (4.0)
Completeness (%) 95.6 (70.3) 98.6 (93.3) 95.6 (92.8) 99.2 (96.0)
Redundancy 6.6 (4.0) 5.3 (6.9) 4.6 (3.6) 3.7 (3.5)
Unique reflections 50454 26485 80522 39703
No. of reflections used 43737 26460 73073 37717
Refinement
Resolution (A ˚) 1.76 1.68 1.45 1.80
Rwork,R free
d 18.8/22.7 21.4/24.1 19.2/22.6 18.6/24.0
No. of atoms
Protein 3692 1739 3500 3543
Water 357 180 380 273
Ligand(s) 10 31 88 102
B factors [average B value (A ˚ 2)for the refined atoms]
Protein 27.5 31.3 23.0 21.7
Water 35.9 37.9 36.5 33.2
Ligand(s) 61.2 85.8 67.6 69.3
R.m.s deviations
Bond lengths (A ˚) 0.006 0.006 0.006 0.011
Bond angles (u) 1.04 1.11 1.02 1.83
*Highest resolution shell is shown in parenthesis.
abeam line ID29 at European Synchrotron Radiation Facility at Grenoble in France.
bPX beam line at Swiss Light Source, Paul Scherrer Institut 5232 Villigen PSI Switzerland.
cRmeas is the redundancy-independent merging R-factor (intensities) Rmeas =(Sh(n/(n-1))
0.5 Sj|I ˆh -Ihj|)/(ShjIhj) with I ˆh =(SjIhj)/nj Where N is the number of times
a given observation has been observed (ie j=1, n).
d3% of the total reflections were excluded for cross-validation.
doi:10.1371/journal.pone.0036526.t002
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using the structure of b-spectrin in complex with Ins(1,4,5)P3 [18].
The Ins(4)P and phosphoserine molecules superposed well on to
the Ins(1,4,5)P3 of the b-spectrin PH complex positioned in the
non-canonical binding site. The resulting model shows that the
PtdIns(4,5)P2 fits well within the binding site, making contact with
all conserved residues (Figure 3B). This again suggests a key role
for residues Arg478, Tyr485, Lys542 and Lys562 in building
a positively charged array that is essential for the correct
orientation and anchoring of the PH domain to PtdIns(4,5)P2--
containing membranes. Overall, our results are consistent with the
view that the yeast Slm1-PH belongs to the class of PH domains
that bind ligands through a non-canonical binding site. Therefore,
this type of PH domain is not restricted to higher eukaryotes, and
has been conserved from yeast to mammals.
Potential binding sites for a second anionic lipid head
group
It has been shown that in vitro, Slm1-PH binds to both PtdInsPs
(PtdIns(4)P, PtdIns(4,5)P2) [9] and DHS-1P in a cooperative
manner [12]. We therefore proposed that the Slm1-PH contains
both non-canonical and canonical binding sites. Consistent with
this hypothesis, our structure here reveals ligand bound in the non-
canonical binding site and an additional positively charged region
in the canonical binding site that remains available for binding to
additional negatively charged head groups (Figure 4A). This
encompasses the Arg477, Lys480 and Lys483 residues that point
towards the canonical binding site and are important for the
recruitment of Slm1 to biological membranes in vivo [12].
Interestingly, we also observed extra electron densities next to
the canonical binding site that could be filled with a phosphate
group (Figure 4 and Figure S3A). However, the identity of the
ligand could not be unambiguously determined. Crystallization
conditions did not contain any phosphate ion but the buffer was
mildly acidic (pH 6.5), which could lead to partial hydrolysis. This
could become significant given the high concentration of ligand
used (10-fold excess over Slm1-PH) and the long incubation time
(one week) required to obtain optimal crystals. Another possibility
is that the full Ins(4)P bound, but the electron density for the
inositol ring was too poor to be built. Consistent with the latter, we
observed that by slightly loosening the restraints, a region of
density in continuation with the phosphate group emerged in one
out of four molecules in the asymmetric unit. We could fit an
inositol ring in this region, even though the densities for some of
the hydroxyl groups were missing at 1 sigma level (Figure S3B).
This phosphate group lies in the cavity formed by His557, His546,
Trp559, Val544 and Phe481 of the neighboring molecule. The
oxygen atoms of the phosphate group interact with the e-amino
group of positively charged Lys480 (bond length =3.2 A ˚), ND1 of
His557, the ND2 atom of Asn558, and the main-chain nitrogen
atom of Asn558 (bond lengths =2.6 A ˚, 2.9 A ˚ and 2.4 A ˚
Figure 2. Detailed stereo diagrams of bound ligands. (A) Interactions made by Ins(4)P (green) and the residues at the non-canonical binding
site of Slm1-PH (also in green). The phosphate group of Ins(4)P is making contacts with the b1-b2 region (residues involved are shown in red).
Residues critically involved in the interactions are labeled by the single-letter code and shown in stick representation (see text for details). (B) The
Ins(4)P is shown in the experimental 2Fo-Fc electron density map at 1.2 sigma level. The water molecule (red) corresponds to P1 position of
Ins(1,4,5)P when docked into the non-canonical binding site. Position of the Ins(4)P is oriented to maximize the clarity of the figure. (C) Similar
interactions are shown here with the Ins(4)P molecule for which the phosphate position is seen on the opposite side of the binding pocket, making
contacts with residues of b5-b6 (again in red). (D) Stereo representation of phosphoserine bound in the non-canonical binding site. The dashed lines
shown between atoms represent hydrogen bonds between ligand(s) and the residues at the non-canonical binding site of Slm1-PH.
doi:10.1371/journal.pone.0036526.g002
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that the long and flexible side-chain of Arg477 points towards the
phosphate group (bond length =8.5 A ˚) (Figure 4B) and the two
could be modeled as close as 3 A ˚ (Figure S3C). Our structures
show that, along with other residues, Arg477 and Arg478
contribute to ligand binding in both of the two putative binding
sites (Figure 4B and Figure S4). This is consistent with previous
analyses, which showed that mutation of these residues to alanine
either alone or in combination caused defects in Slm1 function
and its ability to associate with biological membranes ([12] and
Figure S4). The stronger and apparently cumulative effect of the
double mutant supports the view that binding to both sites is
required for Slm1 function. Taken together, our results clearly
suggest the existence of an additional positively charged binding
region adjacent to the non-canonical binding site.
Comparison of Slm1-PH domain with other PH domains
Several structures of different PH domains have been de-
termined using X-ray crystallography or nuclear magnetic
resonance (NMR) spectroscopy [18,27,28,29,30]. Many of these
are in complex with inositol phosphate ligand bound in either the
canonical or the non-canonical binding site (Figure 5). Irrespective
Figure 3. Superposition of Slm1-PH domain structures. (A) The different ligands (sulfate (violet), phosphoserine (salmon), Ins(4)P (green) and
also the turned-over Ins(4)P (light blue)) are occupying the same non-canonical binding pocket, confirming the readily available large binding siteo f
the Slm1-PH. (B) Stereo diagram of PtdIns(4,5)P2 (atom colors) modeled in the non-canonical binding site of Slm1-PH (green) and overlaid onto the b-
spectrin PH domain (wheat color). This shows the conservation of side chains that contact the ligands.
doi:10.1371/journal.pone.0036526.g003
Figure 4. Surface charge distribution. (A) The Slm1-PH provides a positively-charged cavity to interact with a negatively charged Ins(4)P
molecule (in green). The back of the b1-b2 region (by rotating Slm1-PH by 180 degrees) shows a more positively charged region. In several structures
of Slm1-PH determined in complex with ligand analogs, we built a phosphate group or full Ins(4)P at this additional positively charged site (see text
for details). The Arg477 side chain that turns towards the canonical binding site is also shown in transparent stick format. (B) Stereo diagram of Slm1-
PH (green) showing Arg477, Arg478, Lys480 and Lys483 on either side of the b1-b2 strands in the vicinity of the negatively charged residues of the
b5-b6 loop of the neighboring molecule (cyan). Part of the b5-b6 loop is truncated for the clarity of the figure. The bound phosphate group is shown
in stick representation at the back of the b1-b2 region towards the canonical binding site. We have modeled the natural ligand (DHS-1P in yellow)
aligning with the phosphate position in this region. Ins(4)P is also shown in the non-canonical binding site.
doi:10.1371/journal.pone.0036526.g004
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positively charged residues within the b1-b2 loop region are
relatively conserved (Figure 6; black box). A structure-based
sequence alignment with other PH domains reveals that Slm1-PH
is most similar to the PH domains of b-spectrin, Tiam1 and
ArhGAP9, which bind to ligands through their non-canonical
sites. The superposition of Slm1-PH onto the PH domain of b-
spectrin shows the conserved b1-b2 loop region accommodating
the ligand in the non-canonical binding site (Figure 5D and F).
Indeed, Slm1-PH lacks the characteristic KXK/RXR motif in the
b1-b2 loop that is present in PH domains with a canonical binding
site (b/akt, Btk, Grp1 and PLCd [5,6,8,18,19] (Figure 5E and F).
Also in Slm1-PH, the most conserved positively charged residue
within the b1-b2 loop (Arg478) is flipped towards the non-
canonical binding site to interact with the Ins(4)P molecule. In
PLCd, a small valine residue occupies a similar position and also
points towards the non-canonical binding site. This is consistent
with the fact that the space between the b1-b2 and the b5-b6 loops
is very narrow, which excludes the non-canonical binding mode in
PLCd (Figure S4).
Figure 5. Comparison of canonical and non-canonical binding sites. (A) Structure of the PLCd (1MAI.PDB) in steel blue with bound
Ins(1,4,5)P3 in the canonical binding site, which is formed by b1-b2, b3-b4 and b6-b7 loop regions; (B) Cartoon representation of Slm1-PH in green,
Ins(4)P is bound in the non-canonical binding site; (C) Structure of the b-spectrin PH domain (1BTN.PDB) in wheat color with bound Ins(1,4,5)P3 again
in the non-canonical binding site. (D) Superposition of the Slm1-PH (green) modeled with Ins(1,4,5)P3 onto the b-spectrin PH domain (wheat) and (E)
onto PLCd (cyan) (F) LIGPLOT representation [38] showing residues involved in ligand binding in the non-canonical binding site (Slm1-PH and b-
spectrin) and the canonical binding site (PLCd). The conserved residues between PH domains of Slm1 and b-spectrin involved in ligand binding are
highlighted in pale yellow.
doi:10.1371/journal.pone.0036526.g005
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Slm1-PH contains a conserved R/KXW motif, which is involved
in ligand binding at the non-canonical binding site. The only
minor difference is that the tryptophan is replaced by another
aromatic residue, Tyr485. We also observe interesting differences
between Slm1-PH and b-spectrin, Tiam1 and ArhGAP9 that may
account for the dual binding specificity of Slm1-PH. For example,
a non-conserved positively charged residue (Lys542) participates in
ligand binding in the Slm1 PH, whereas a series of positively
charged residues are absent within the b5-b6 loop region. Finally,
in the case of Slm1-PH, ligand binding is also supported by Lys562
of the b6-b7 region (Figure 6), which is not conserved in other PH
domains. These differences are consistent with the hypothesis that
Slm1-PH may have altered binding properties compared with
previously characterized PH domains.
In summary, here we present the first three-dimensional
structures of the Slm1-PH bound to Ins(4)P and phosphoserine
and show that the Slm1-PH exhibits a non-canonical PtdInsPs-
binding mechanism. The non-canonical binding site is shallow,
large and solvent-exposed, and so the phosphate position of Ins(4)P
in one of the structures was seen on the opposite side of the
molecule. The non-canonical binding site accommodated anions
from the crystallization conditions, and also the phosphoserine
molecule. The long b5-b6 loop occupied part of the space at the
canonical binding cavity, making it less available for ligand
binding. We nevertheless observed a large positively charged
region behind the b1-b2 loop towards the canonical binding site
that associated with a phosphate group. This putative binding
surface could accommodate a second ligand and account for the
cooperative binding described for the Slm1-PH.
Materials and Methods
Expression, purification and crystallization
The Slm1-PH was expressed from Escherichia coli and purified
using affinity chromatography. Cloning, expression and purifica-
tion of the recombinant protein used in this study were performed
using the methods described previously [12].
Crystallization of the Slm1-PH domain
Initial apo crystals of the Slm1-PH were obtained through
a screen with the mosquito crystallization robot (TTP Labtech)
using the sitting drop vapor diffusion technique in 96-well plates
with drop and reservoir volumes of 0.2 ml and 100 ml, respectively.
Crystals were routinely grown in 24-well plates (Hampton
Research) at 15uC by the hanging drop vapor diffusion technique.
Equal volumes (0.75 ml/0.75 ml) of protein (15 mg/ml) and
crystallization buffer (0.1 M MES + 30% PEG5000 + 0.2 M
ammonium sulfates, pH 6.5) were mixed on a cover slip, which
was subsequently equilibrated against a reservoir containing
500 ml of crystallization buffer. Micro-seeding was used to obtain
larger single crystals. The optimal hexagonal crystals grew in
about eight days to a size of approximately 100 mm 6100 mm 6
50 mm. Subsequently, sulfate ions were replaced with malonate in
the crystallization conditions (0.1 M MES + 28% PEG5000 +
0.2 M sodium malonate, pH 6.5) to avoid interference with ligand
binding.
Co-crystallization and soaking techniques were used to obtain
complex crystals. Several crystals of Slm1-PH were obtained with
and without head group analogues of PtdInsPs and lipids (Table 1).
Crystals of Slm1-PH in complex with Ins(4)P were obtained by
using 10-fold molar excess of Ins(4)P (Sigma Aldrich). Monoclinic
rod-like crystals formed in about a week and grew to approxi-
mately 150 mmx9 0 mm x 300 mm from the crystallization
Figure 6. Structure-based sequence alignment of PH domains of Slm1, b-spectrin and PLCd. The alignment was produced using the
PROMALS3D program [39] and corrected manually on the basis of the three-dimensional structure of the Slm1-PH. The matched-up sequences were
from RCSB/PDB. The secondary structure elements revealed in the Slm1-PH crystal structure are shown above the sequence: b-sheets are shown by
blue arrows and the C-terminal helix by an orange cylinder. The residues of Slm1-PH involved in Ins(4)P interaction are shown in red. The residues
highlighted in yellow are aligned with the ligand-interacting residues of the Slm1-PH. Residues of different classes of PH domains that are involved in
ligand binding are shown in ‘bold’. The R/KXR and R/KXW motifs for ligand binding in the canonical and non-canonical binding sites respectively, are
shown in the black box. The structure-based sequence alignment showing overall conserved or semi-conserved residues are represented in grey.
Sequences are grouped according to ligand binding in the non-canonical and canonical binding pockets.
doi:10.1371/journal.pone.0036526.g006
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sodium malonate, pH 5.5. All crystals were harvested by transfer
to a cryo-protectant solution of 15% ethylene glycol in the mother
liquor, rapidly collected in a nylon loop (Hampton Research,
USA) and flash-cooled in liquid nitrogen.
Data collection, structure determination and refinement
Data were collected at various synchrotron beamlines at the
European Synchrotron Radiation Facility (ESRF) in Grenoble,
France and the Swiss Light Source (SLS) in Villigen, Switzerland.
All the data sets were processed and scaled using the XDS
program package [31]. For all the structures presented here, the
phase problem was solved by molecular replacement [32] using
the program PHASER [33] and the coordinates of apo Slm1-PH
(3NSU; [12]) as a search model. Two flexible loops (residues: 501–
512 and 526–542) of the search model were truncated for the
phase solution. The model was refined in alternating cycles of
refinement with PHENIX [34]. Manual rebuilding and visual
comparisons were made using the graphical program COOT [35].
The stereo chemical quality of the final model was assessed
using PROCHECK [36]. Molecular diagrams were drawn using
the PyMOL molecular graphics suite [37]. Details of the diffraction
data collection, quality and refinement statistics are given in
Table 2.
Protein databank accession number
The atomic coordinates and structure factor amplitudes have
been deposited in the Protein Data Bank Europe, http://www.ebi.
ac.uk/pdbe/ [PDB ID codes: 4A5K, 4A6F, 4A6H and 4A6K].
Supporting Information
Figure S1 Chemical drawings of the physiological
ligands of the Slm1-PH. The head-group mimics, Ins(4)P
and phosphoserine, are indicated by red circles.
(TIF)
Figure S2 Experimental Fo-Fc electron density map
prior to modeling of a bound Ins(4)P molecule, con-
toured at 2.5 sigma level. Ins(4)P molecule and the residues
involved in the interaction are shown in the stick format and
labeled accordingly.
(TIF)
Figure S3 Phosphate positioned in the cavity at the back
of the b1-b2 region. (A) Interaction with the residues of the b1-
b2 and b6-b7 loops. The phosphate group and the residues
involved in the interaction are shown in ball-and-stick format in
the ribbon diagram of Slm1-PH in green. All the hydrogen bonds
are shown by dashed lines. (B) Cartoon representation of Slm1-PH
with Ins(4)P bound at the back of the b1-b2 loop region in one out
of four molecules in the asymmetric unit. (C) Here we modeled/
rotated the side chain of Arg477 (already facing towards the
phosphate of Ins(4)P) that can come to within 3 A ˚ of the phosphate
group.
(TIF)
Figure S4 Superposition of the conserved Arg477 and
Arg478 of Slm1-PH (green) onto the residues Lys and Val
of PLCd (teal color) and Arg and Lys of b-spectrin (wheat
color) PH domains. (B) Impact of Arg477 and Arg478 mutation
to alanine on Slm1 recruitment to biological membranes and Slm1
function in vivo, i.e. yeast growth and actin polarization. Adapted
from [12].
(TIF)
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